TOR rules | Death | Survival | Sensitivity (95% CI) | Specificity (95% CI) | FPV (95% CI) | PPV (95% CI) | NPV (95% CI) | |
---|---|---|---|---|---|---|---|---|
Before arriving at the ED | ||||||||
 International BLS-TOR | met all criteria | 121 | 1 | 74.2% | 85.7% | 0.8% | 99.2% | 12.5% |
did not fulfill | 42 | 6 | (66.7–80.6) | (42.0–99.2) | (0.04–5.2) | (84.8–99.9) | (5.2–25.9) | |
 Goto’s rule | met all criteria | 58 | 0 | 35.6% | 100% | 0% | 100% | 6.3% |
did not fulfill | 105 | 7 | (28.4–43.5) | (56.1–100) | (0–7.7) | (92.3–100) | (2.8–12.9) | |
 KoCARC TOR rule I | met all criteria | 93 | 0 | 57.1% | 100% | 0% | 100% | 9.1% |
did not fulfill | 70 | 7 | (49.1–64.7) | (56.1–100) | (0–4.9) | (95.1–100) | (4.0–18.4) | |
 KoCARC TOR rule II | met all criteria | 97 | 1 | 56.5% | 85.7% | 1.0% | 98.9% | 8.3% |
did not fulfill | 66 | 6 | (51.5–67.0) | (42.0–99.2) | (0.05–6.4) | (93.6–99.9) | (3.4–17.9) | |
 KoCARC TOR rule III | met all criteria | 78 | 0 | 47.9% | 100% | 0% | 100% | 7.6% |
did not fulfill | 85 | 7 | (40.0–55.8) | (56.1–100) | (0–5.8) | (94.2–100) | (3.4–15.6) | |
 New TOR Model 1 | met all criteria | 35 | 0 | 21.5% | 100% | 0% | 100% | 5.2% |
did not fulfill | 128 | 7 | (15.6–28.7) | (56.1–100) | (0–12.3) | (87.7–100) | (2.3–10.8) | |
After ED arrival | ||||||||
 International ALS TOR | met all criteria | 23 | 0 | 14.1% | 100% | 0 | 100% | 4.8% |
did not fulfill | 140 | 7 | (9.3–20.6) | (56.1–100) | (0–17.8) | (82.2–100) | (2.1–9.9) | |
 SOS-KANTO’s rule | met all criteria | 33 | 0 | 20.2% | 100% | 0% | 100% | 5.2% |
did not fulfill | 130 | 7 | (14.5–27.4) | (56.1–100) | (0–12.9) | (87.0–100) | (2.3–10.6) | |
 New TOR Model 2 | met all criteria | 45 | 0 | 27.6% | 100% | 0% | 100% | 5.6% |
did not fulfill | 118 | 7 | (21.0–35.2) | (56.1–100) | (0–9.7) | (90.2–100) | (2.4–11.6) |